Health care utilization in patients with spondyloarthropathies

Rheumatology

Volumn 48, Issue 3, 2009, Pages 272-276

  Singh, Jasvinder A ^a,b,c   Strand, V ^d  

^a VA MEDICAL CENTER   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ankylosing spondylitis; Health care use; Health care utilization; Predictors; Psoriatic arthritis; Reactive arthritis; Resource utilization

Indexed keywords

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTPATIENT; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; RESOURCE MANAGEMENT; SMOKING; SURGICAL TECHNIQUE; VETERAN;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, REACTIVE; COHORT STUDIES; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES RESEARCH; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; SPONDYLARTHROPATHIES; SPONDYLITIS, ANKYLOSING; UNITED STATES;

EID: 61349101588     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken472     Document Type: Article

References (30)

1. Salaffi F, De Angelis R, Stancati A, Grassi W. Health-related quality of life in multiple musculoskeletal conditions: A cross-sectional population based epidemiological study. II. The mapping study. Clin Exp Rheumatol 2005;23:829-39.
2. Boonen A, van den Heuvel R, van Tubergen A et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 2005;64:396-402.
3. Boonen A, van der Heijde D, Landewe R et al. Direct costs of ankylosing spondylitis and its determinants: An analysis among three European countries. Ann Rheum Dis 2003;62:732-40.
4. Boonen A, van der Heijde D, Landewe R et al. Costs of ankylosing spondylitis in three European countries: The patient's perspective. Ann Rheum Dis 2003;62: 741-7.
5. Kobelt G, Andlin-Sobocki P, Maksymowych WP. Costs and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 2006;33:289-95.
6. Verstappen SM, Jacobs JW, van der Heijde DM et al. Utility and direct costs: Ankylosing spondylitis compared with rheumatoid arthritis. Ann Rheum Dis 2007;66:727-31.
7. Zink A, Thiele K, Huscher D et al. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2006;33:86-90.
8. Roberts RO, Bergstralh EJ, Schmidt L, Jacobsen SJ. Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol 1996;49: 989-95.
9. Ward MM. Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum 2002;46:223-31.
10. Perlin JB, Kolodner RM, Roswell RH. The Veterans Health Administration: quality, value, accountability, and information as transforming strategies for patient-centered care. Am J Manag Care 2004;10:828-36.
11. Yu W, Ravelo A, Wagner T et al. Prevalence and costs of chronic conditions in the VA health care system. Med Care 2003;60:146S-67S.
12. Singh JA, Borowsky SJ, Nugent S et al. Health-related quality of life, functional impairment, and healthcare utilization by veterans: veterans' quality of life study. J Am Geriatr Soc 2005;53:108-13.
13. Katz S FA, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in aged: The inAex of ADL: a standard measure of biological and psychological function. J Am Med Assoc 1963;185:914-9.
14. Dunlop DD, Semanik P, Song J, Manheim LM, Shih V, Chang RW. Risk factors for functional decline in older adults with arthritis. Arthritis Rheum 2005;52:1274-82.
15. Hamman RF, Mulgrew CL, Baxter J, Shetterly SM, Swenson C, Morgenstern NE. Methods and prevalence of ADL limitations in hispanic and non-hispanic white subjects in rural Colorado: The San Luis Valley Health and Aging Study. Ann Epidemiol 1999;9:225-35.
16. Singh JA, Holmgren AR, Krug H, Noorbaloochi S. Accuracy of the diagnoses of spondylarthritides in Veterans Affairs medical center databases. Arthritis Rheum 2007;57:648-55.
17. Heo S, Moser DK, Lennie TA, Zambroski CH, Chung ML. A comparison of health-related quality of life between older adults with heart failure and healthy older adults. Heart Lung 2007;36:16-24.
18. Chisholm MA, Spivey CA, Nus AV. Influence of economic and demographic factors on quality of life in renal transplant recipients. Clin Transplant 2007;21:285-93.
19. Borowiak E, Kostka T. Predictors of quality of life in older people living at home and in institutions. Aging Clin Exp Res 2004;16:212-20.
20. Dunlop DD, Manheim LM, Song J, Chang RW. Arthritis prevalence and activity limitations in older adults. Arthritis Rheum 2001;44:212-21.
21. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997;50:1129-36.
22. Bostan EE, Borman P, Bodur H, Barca N. Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 2003;23:121-6.
23. Dagfinrud H, Kjeken I, Mowinckel P, Hagen KB, Kvien TK. Impact of functional impairment in ankylosing spondylitis: Impairment, activity limitation, and participation restrictions. J Rheumatol 2005;32:516-23.
24. Dagfinrud H, Mengshoel AM, Hagen KB, Loge JH, Kvien TK. Health status of patients with ankylosing spondylitis: A comparison with the general population. Ann Rheum Dis 2004;63:1605-10.
25. Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: A comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001;45:151-8.
26. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28:1842-6.
27. Mease PJ, Kivitz AJ, Burch FX et al. Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression. Arthritis Rheum 2004;50: 2264-72.
28. Kavanaugh A, Antoni C, Krueger GG et al. Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis. Ann Rheum Dis 2006;65:471-7.
29. Mease PJ, Gladman DD, Ritchlin CT et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005;52:3279-89.
30. Kimball AB, Jackson JM, Sobell JM et al. Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: Results from the educate trial. J Drugs Dermatol 2007;6:299-306.